118 related articles for article (PubMed ID: 28982885)
1. Potential Pitfalls of a Fiducial Marker-matching Technique in Carbon-ion Radiotherapy for Lung Cancer.
Shiba S; Saitoh JI; Irie D; Shirai K; Abe T; Kubota Y; Sakai M; Okada R; Ohno T; Nakano T
Anticancer Res; 2017 Oct; 37(10):5673-5680. PubMed ID: 28982885
[TBL] [Abstract][Full Text] [Related]
2. Verification of Dose Distribution in Carbon Ion Radiation Therapy for Stage I Lung Cancer.
Irie D; Saitoh JI; Shirai K; Abe T; Kubota Y; Sakai M; Noda SE; Ohno T; Nakano T
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1117-1123. PubMed ID: 27869084
[TBL] [Abstract][Full Text] [Related]
3. Technical Note: Predicting dose distribution with replacing stopping power ratio for inter-fractional motion and intra-fractional motion during carbon ion radiotherapy with passive irradiation method for stage I lung cancer.
Kubota Y; Sakai M; Tashiro M; Saitoh JI; Abe T; Ohno T; Nakano T
Med Phys; 2018 Jul; 45(7):3435-3441. PubMed ID: 29757472
[TBL] [Abstract][Full Text] [Related]
4. Robustness of patient positioning for interfractional error in carbon ion radiotherapy for stage I lung cancer: Bone matching versus tumor matching.
Sakai M; Kubota Y; Saitoh JI; Irie D; Shirai K; Okada R; Torikoshi M; Ohno T; Nakano T
Radiother Oncol; 2018 Oct; 129(1):95-100. PubMed ID: 29100701
[TBL] [Abstract][Full Text] [Related]
5. Fiducial marker placement via conventional or electromagnetic navigation bronchoscopy (ENB): an interdisciplinary approach to the curative management of lung cancer.
Hagmeyer L; Priegnitz C; Kocher M; Schilcher B; Budach W; Treml M; Stieglitz S; Randerath W
Clin Respir J; 2016 May; 10(3):291-7. PubMed ID: 25308297
[TBL] [Abstract][Full Text] [Related]
6. Fiducial marker matching versus vertebral body matching: Dosimetric impact of patient positioning in carbon ion radiotherapy for primary hepatic cancer.
Abe S; Kubota Y; Shibuya K; Koyama Y; Abe T; Ohno T; Nakano T
Phys Med; 2017 Jan; 33():114-120. PubMed ID: 28057427
[TBL] [Abstract][Full Text] [Related]
7. A potential to reduce pulmonary toxicity: the use of perfusion SPECT with IMRT for functional lung avoidance in radiotherapy of non-small cell lung cancer.
Lavrenkov K; Christian JA; Partridge M; Niotsikou E; Cook G; Parker M; Bedford JL; Brada M
Radiother Oncol; 2007 May; 83(2):156-62. PubMed ID: 17493699
[TBL] [Abstract][Full Text] [Related]
8. Liquid fiducial marker performance during radiotherapy of locally advanced non small cell lung cancer.
Rydhög JS; Mortensen SR; Larsen KR; Clementsen P; Jølck RI; Josipovic M; Aznar MC; Specht L; Andresen TL; Rosenschöld PM; Persson GF
Radiother Oncol; 2016 Oct; 121(1):64-69. PubMed ID: 27443450
[TBL] [Abstract][Full Text] [Related]
9. Inter-fractional error and intra-fractional motion of prostate and dosimetry comparisons of patient position registrations with versus without fiducial markers during treatment with carbon-ion radiotherapy.
Iwai Y; Mori S; Ishikawa H; Kanematsu N; Matsumoto S; Nakaji T; Okonogi N; Kobayashi K; Wakatsuki M; Uno T; Yamada S
Radiol Phys Technol; 2024 Jun; 17(2):504-517. PubMed ID: 38691309
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of different fiducial markers for image-guided radiotherapy and particle therapy.
Habermehl D; Henkner K; Ecker S; Jäkel O; Debus J; Combs SE
J Radiat Res; 2013 Jul; 54 Suppl 1(Suppl 1):i61-8. PubMed ID: 23824129
[TBL] [Abstract][Full Text] [Related]
11. Interfractional positional variability of fiducial markers and primary tumors in locally advanced non-small-cell lung cancer during audiovisual biofeedback radiotherapy.
Roman NO; Shepherd W; Mukhopadhyay N; Hugo GD; Weiss E
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1566-72. PubMed ID: 22391105
[TBL] [Abstract][Full Text] [Related]
12. [Impact of PET/CT on precise radiotherapy planning for non-small cell lung cancer].
Gong HY; Yu JM; Fu Z; Li BS; Li JB; Liu TH
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):54-7. PubMed ID: 16737623
[TBL] [Abstract][Full Text] [Related]
13. [Relationship of dose-volume histogram parameters and computed tomography grading of radiation-induced lung injury in patients with non-small cell lung cancer treated by three-dimensional conformal radiotherapy].
Xing J; Li JB; Yu JM; Lu J; Xu M; Fan TY; Shao Q; Guo SF
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):676-81. PubMed ID: 19173909
[TBL] [Abstract][Full Text] [Related]
14. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.
Bradley J; Thorstad WL; Mutic S; Miller TR; Dehdashti F; Siegel BA; Bosch W; Bertrand RJ
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):78-86. PubMed ID: 15093902
[TBL] [Abstract][Full Text] [Related]
15. Radiographic pulmonary and pleural changes after carbon ion irradiation.
Nishimura H; Miyamoto T; Yamamoto N; Koto M; Sugimura K; Tsujii H
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):861-6. PubMed ID: 12605963
[TBL] [Abstract][Full Text] [Related]
16. A clinical study of shrinking field radiation therapy based on (18)F-FDG PET/CT for stage III non-small cell lung cancer.
Ding X; Li H; Wang Z; Huang W; Li B; Zang R; Sun H; Yi Y
Technol Cancer Res Treat; 2013 Jun; 12(3):251-7. PubMed ID: 23289475
[TBL] [Abstract][Full Text] [Related]
17. Effect of patient positioning on carbon-ion therapy planned dose distribution to pancreatic tumors and organs at risk.
Miki K; Fukahori M; Kumagai M; Yamada S; Mori S
Phys Med; 2017 Jan; 33():38-46. PubMed ID: 28003135
[TBL] [Abstract][Full Text] [Related]
18. Dose assessment for patients with stage I non-small cell lung cancer receiving passive scattering carbon-ion radiotherapy using daily computed tomographic images: A prospective study.
Li Y; Kubota Y; Kubo N; Mizukami T; Sakai M; Kawamura H; Irie D; Okano N; Tsuda K; Matsumura A; Saitoh JI; Nakano T; Ohno T
Radiother Oncol; 2020 Mar; 144():224-230. PubMed ID: 32044421
[TBL] [Abstract][Full Text] [Related]
19. Incidence, risk factors, and dose-volume relationship of radiation-induced rib fracture after carbon ion radiotherapy for lung cancer.
Abe T; Shirai K; Saitoh J; Ebara T; Shimada H; Tashiro M; Okano N; Ohno T; Nakano T
Acta Oncol; 2016; 55(2):163-6. PubMed ID: 26399488
[TBL] [Abstract][Full Text] [Related]
20. Comparison between bone matching and marker matching for evaluation of intra- and inter-fractional changes in accumulated dose of carbon ion radiotherapy for hepatocellular carcinoma.
Kubota Y; Katoh H; Shibuya K; Shiba S; Abe S; Sakai M; Yuasa D; Tsuda K; Ohno T; Nakano T
Radiother Oncol; 2019 Aug; 137():77-82. PubMed ID: 31078014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
